poisar

Stocks · News reference

FDA Greenlights GSK’s First Lung Cancer Drug Ahead of Schedule

BenzingaJul 22, 2026, 5:39 PMVandana Singh

GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positive non-small cell lung cancer.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 22, 2026, 5:39 PM
Checked
Jul 22, 2026, 5:39 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading